Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin G Sanda

Showing results (11-20 of 180) with videos related to

Pageof 18
Sort By:
The Journal of Urology|September 28, 2002
Contemporary diagnosis and management of renal angiomyolipomaCaleb P Nelson, Martin G Sanda
JAMA|May 7, 2009
A 64-year-old man with low-risk prostate cancer: review of prostate cancer treatmentMartin G Sanda, Irving D Kaplan
Nature Clinical Practice. Urology|February 5, 2009
Health-related quality-of-life effects of watchful waiting re-evaluated in SPCG-4David W McDermott, Martin G Sanda
Seminars in Radiation Oncology|December 18, 2007
Measuring health-related quality of life consequences from primary treatment for early-stage prostate cancerSavita V Dandapani, Martin G Sanda
Oncology (Williston Park, N.Y.)|December 2, 2009
Further perspectives on treating localized prostate cancerJoseph A Aronovitz, Martin G Sanda
Molecular Aspects of Medicine|May 30, 2015
RNA biomarkers to facilitate the identification of aggressive prostate cancerKathryn L Pellegrini, Martin G Sanda, Carlos S Moreno
Biometrics|November 23, 2021
Covariate adjustment in continuous biomarker assessmentZiyi Li, Yijian Huang, Dattatraya Patil, et al.
Statistica Sinica|May 16, 2023
Interval estimation for operating characteristic of continuous biomarkers with controlled sensitivity or specificityYijian Huang, Isaac Parakati, Dattatraya H Patil, et al.
Urologic Oncology|August 6, 2021
Cancer-specific outcomes for prostate cancer patients who had prebiopsy prostate MRIJonathan Li, Dattatraya Patil, Martin G Sanda, et al.
Statistics in Medicine|January 4, 2023
Covariate-specific evaluation of continuous biomarkerZiyi Li, Yijian Huang, Dattatraya Patil, et al.
Pageof 18

Showing results (11-20 of 180) with videos related to

Sort By:
Pageof 18
The Journal of Urology|September 28, 2002
Contemporary diagnosis and management of renal angiomyolipomaCaleb P Nelson, Martin G Sanda
JAMA|May 7, 2009
A 64-year-old man with low-risk prostate cancer: review of prostate cancer treatmentMartin G Sanda, Irving D Kaplan
Nature Clinical Practice. Urology|February 5, 2009
Health-related quality-of-life effects of watchful waiting re-evaluated in SPCG-4David W McDermott, Martin G Sanda
Seminars in Radiation Oncology|December 18, 2007
Measuring health-related quality of life consequences from primary treatment for early-stage prostate cancerSavita V Dandapani, Martin G Sanda
Oncology (Williston Park, N.Y.)|December 2, 2009
Further perspectives on treating localized prostate cancerJoseph A Aronovitz, Martin G Sanda
Molecular Aspects of Medicine|May 30, 2015
RNA biomarkers to facilitate the identification of aggressive prostate cancerKathryn L Pellegrini, Martin G Sanda, Carlos S Moreno
Biometrics|November 23, 2021
Covariate adjustment in continuous biomarker assessmentZiyi Li, Yijian Huang, Dattatraya Patil, et al.
Statistica Sinica|May 16, 2023
Interval estimation for operating characteristic of continuous biomarkers with controlled sensitivity or specificityYijian Huang, Isaac Parakati, Dattatraya H Patil, et al.
Urologic Oncology|August 6, 2021
Cancer-specific outcomes for prostate cancer patients who had prebiopsy prostate MRIJonathan Li, Dattatraya Patil, Martin G Sanda, et al.
Statistics in Medicine|January 4, 2023
Covariate-specific evaluation of continuous biomarkerZiyi Li, Yijian Huang, Dattatraya Patil, et al.
Pageof 18